Please try another search
NIHON CHOUZAI Co.,Ltd. engages in the management of health insurance dispensing chain pharmacies in Japan. It operates through dispensing pharmacy, pharmaceutical manufacturing and sales, and medical staff dispatching and referral business segments. The company manufactures and sells generic drugs to medical institutions and other pharmacies. In addition, it offers temporary staffing services for pharmacist; and employment services for physicians and registered sales personnel, and other healthcare professionals. Further, the company provides studies and research services for pharmaceutical companies and organizations; information and consulting services for industries associated with pharmaceuticals and healthcare; and other services. NIHON CHOUZAI Co.,Ltd. was incorporated in 1980 and is headquartered in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Yosuke Mitsuhara | 45 | 2006 | President, CEO & Representative Director |
Kazunori Ogi | 56 | 2015 | Senior Executive Officer, GM of Finance Department & Director |
Yoshihisa Fujimoto | 64 | 2016 | Senior Executive Officer, GM of Administration General Affairs Department & Executive Director |
Mikiharu Noma | 49 | 2021 | Independent Outside Director |
Arata Toyoshi | 58 | 2019 | Independent Outside Director |
Toshiyuki Koyanagi | 60 | 2009 | Senior Executive Officer, GM of Pharmaceutical Headquarters & Director |
Naoto Kasai | 61 | 2013 | MD, Managing Executive Officer & Director |
Yoshimitsu Onji | 69 | 2018 | Independent Outside Director |
Shio Harada | - | 2022 | Independent Outside Director |
Masahiro Inoue | - | 2023 | Director |
Nobuyuki Hatakeyama | 67 | 2018 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review